Sign inJoin waitlistJoin the waitlist

BC

Barrett Childs

Credentials: ·

Research

Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials
The Lancet Oncology · 2020 · 835 citations
Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3): a double-blind, randomised, placebo-controlled, phase 3…
The Lancet Oncology · 2021 · 118 citations
Long-term safety and efficacy of the PI3K inhibitor copanlisib in patients with relapsed or refractory indolent lymphoma: 2-year follow-up of the CHRONOS-1 study
American Journal of Hematology · 2020 · 116 citations

Matthew Matasar
4 papers
Peter Morcos
4 papers
AD
Alexander Drilon
2 papers
David Hong
2 papers
DH
David Hyman
2 papers
DT
David Trevarthen
2 papers
DS
Don Stevens
2 papers
Jordan Berlin
2 papers
LM
Leo Mascarenhas
2 papers
RS
Russell Schilder
2 papers
Shivaani Kummar
2 papers
Theodore Laetsch
2 papers